Galmed Pharmaceuticals Ltd. (GLMD)

NASDAQ: GLMD · Real-Time Price · USD

1.340

-0.120 (-8.22%)

At close: Apr 4, 2025, 4:00 PM

1.356

+0.016 (1.21%)

After-hours: Apr 4, 2025, 7:50 PM EDT

Galmed Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-7.52	-6.91	-17.87	-32.47	-28.77	Upgrade
Depreciation & Amortization	0.08	0.03	0.04	0.04	0.04	Upgrade
Loss (Gain) From Sale of Investments	1.14	0.03	0.52	0.08	-0.44	Upgrade
Stock-Based Compensation	0.53	0.89	1.3	1.89	2.07	Upgrade
Other Operating Activities	0.61	-0.31	-0.04	0.01	-0.25	Upgrade
Change in Accounts Receivable	-0.19	0.35	0.3	-0.31	0.02	Upgrade
Change in Accounts Payable	-0.57	-0.68	-2.31	-2.18	1.05	Upgrade
Change in Other Net Operating Assets	0.04	0.47	-0.44	0.04	0.01	Upgrade
Operating Cash Flow	-5.88	-6.14	-18.5	-32.89	-26.29	Upgrade
Capital Expenditures	-	-	-0	-0.01	-0.04	Upgrade
Investment in Securities	-0.86	0.8	17.57	11.47	16.58	Upgrade
Other Investing Activities	-0.25	-	-	-0	-	Upgrade
Investing Cash Flow	-1.11	0.8	17.56	11.46	16.54	Upgrade
Issuance of Common Stock	8.79	6.19	0.07	17.37	0.77	Upgrade
Financing Cash Flow	8.79	6.19	0.07	17.37	0.77	Upgrade
Net Cash Flow	1.8	0.85	-0.87	-4.06	-8.98	Upgrade
Free Cash Flow	-5.88	-6.14	-18.51	-32.9	-26.33	Upgrade
Free Cash Flow Per Share	-6.32	-26.59	-132.48	-240.78	-222.72	Upgrade
Levered Free Cash Flow	-4.95	-3.63	-12.16	-21.08	-15.93	Upgrade
Unlevered Free Cash Flow	-4.57	-3.63	-12.16	-21.08	-15.93	Upgrade
Change in Net Working Capital	0.73	-0.13	2.45	2.45	-0.89	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q